IL79681A - Transition metal complexes of growth hormones and their prolonged release compositions - Google Patents

Transition metal complexes of growth hormones and their prolonged release compositions

Info

Publication number
IL79681A
IL79681A IL79681A IL7968186A IL79681A IL 79681 A IL79681 A IL 79681A IL 79681 A IL79681 A IL 79681A IL 7968186 A IL7968186 A IL 7968186A IL 79681 A IL79681 A IL 79681A
Authority
IL
Israel
Prior art keywords
transition metal
metal complexes
prolonged release
release compositions
growth hormones
Prior art date
Application number
IL79681A
Other languages
English (en)
Other versions
IL79681A0 (en
Original Assignee
Int Minerals & Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Minerals & Chem Corp filed Critical Int Minerals & Chem Corp
Publication of IL79681A0 publication Critical patent/IL79681A0/xx
Publication of IL79681A publication Critical patent/IL79681A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL79681A 1985-08-12 1986-08-11 Transition metal complexes of growth hormones and their prolonged release compositions IL79681A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76440085A 1985-08-12 1985-08-12

Publications (2)

Publication Number Publication Date
IL79681A0 IL79681A0 (en) 1986-11-30
IL79681A true IL79681A (en) 1991-06-10

Family

ID=25070628

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79681A IL79681A (en) 1985-08-12 1986-08-11 Transition metal complexes of growth hormones and their prolonged release compositions

Country Status (12)

Country Link
EP (1) EP0216485A1 (zh)
JP (1) JPS6248635A (zh)
KR (1) KR870001825A (zh)
CN (1) CN86105023A (zh)
AU (1) AU596112B2 (zh)
BR (1) BR8603848A (zh)
DK (1) DK384286A (zh)
ES (1) ES2000864A6 (zh)
IL (1) IL79681A (zh)
NZ (1) NZ217175A (zh)
PT (1) PT83187B (zh)
ZA (1) ZA866052B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0343696B1 (en) * 1984-10-04 1996-01-03 Monsanto Company Zinc-associated somatotropins
CA1285874C (en) * 1985-08-23 1991-07-09 Thomas Harry Ferguson Injectable sustained release formulation
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
EP0277043A3 (en) * 1987-01-30 1989-08-23 IMCERA Group Inc. Method for recovering somatotropins from dilute aqueous solution
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US5122512A (en) * 1988-09-12 1992-06-16 Pitman-Moore, Inc. Swine growth promoting composition
AU653325B2 (en) * 1990-02-12 1994-09-29 Lucky Limited A composition durably releasing bioactive polypeptides
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals
DK168790D0 (zh) * 1990-07-13 1990-07-13 Novo Nordisk As
US6894023B1 (en) 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
WO1992017200A2 (en) * 1991-03-28 1992-10-15 Genentech, Inc. Stable growth hormone metal ion formulations
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
US6087324A (en) * 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
SE9303068D0 (sv) * 1993-09-21 1993-09-21 Kabi Pharmacia Ab New use
BR9509201A (pt) * 1994-09-09 1997-12-30 Takeda Chemical Industries Ltd Preparação de liberação sustemtada uso de um sal de metal polivalente insolúvel em água ou ligeiramente solúvel em água e processo para produzir uma preparação de liberação sustentada
EP0835101B1 (en) 1995-06-27 2004-06-09 Takeda Chemical Industries, Ltd. Method of producing sustained-release preparation
US6191107B1 (en) 1997-09-26 2001-02-20 Takeda Chemical Industries, Ltd. Complex of human growth hormone and zinc
US6451347B1 (en) * 1999-03-01 2002-09-17 Alkermes Controlled Therapeutics, Inc. Method for purifying human growth hormone
KR20090007504A (ko) 2000-02-24 2009-01-16 몬산토 테크놀로지 엘엘씨 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
AU5911101A (en) 2000-04-19 2001-10-30 Genentech Inc Sustained release formulations
MXPA03000073A (es) 2000-06-26 2003-09-25 Monsanto Technology Llc Formulaciones que contienen agente tensioactivo no acuoso para la liberacion prolongada de somatrotopina.
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
CA2418960A1 (en) 2000-08-07 2002-02-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
DE60231862D1 (de) 2001-02-23 2009-05-20 Genentech Inc Erodierbare polymere zur injektion
WO2003000282A1 (en) * 2001-06-21 2003-01-03 Genentech, Inc. Sustained release formulation
BR0317896A (pt) * 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Complexos de cristais de proteìna e polìmeros iÈnicos
BR0317888A (pt) 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
CN102666578A (zh) 2009-12-21 2012-09-12 Ambrx公司 经过修饰的猪促生长素多肽和其用途
EA201290541A1 (ru) 2009-12-21 2013-05-30 Амбркс, Инк. Модифицированные бычьи соматотропиновые полипептиды и их применение
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB885798A (en) * 1958-12-06 1961-12-28 Organon Labor Ltd Preparations of the growth hormone
DK100792C (da) * 1961-05-23 1965-01-18 Dumex Ltd As Fremgangsmåde til fremstilling af et præparat med protraheret vitamin B12-virkning.
DE2158123A1 (de) * 1970-12-02 1972-06-08 Ciba-Geigy Ag, Basel (Schweiz) Neue pharmazeutische Präparate
US4333919A (en) * 1979-09-12 1982-06-08 Eli Lilly And Company Growth promotant controlled release formulations and method of treatment

Also Published As

Publication number Publication date
BR8603848A (pt) 1987-03-24
PT83187B (pt) 1988-07-01
KR870001825A (ko) 1987-03-28
PT83187A (en) 1986-09-01
AU596112B2 (en) 1990-04-26
NZ217175A (en) 1989-11-28
DK384286A (da) 1987-02-13
ES2000864A6 (es) 1988-03-16
IL79681A0 (en) 1986-11-30
AU6109286A (en) 1987-02-19
JPS6248635A (ja) 1987-03-03
EP0216485A1 (en) 1987-04-01
DK384286D0 (da) 1986-08-12
ZA866052B (en) 1987-03-25
CN86105023A (zh) 1988-02-24

Similar Documents

Publication Publication Date Title
IL79681A (en) Transition metal complexes of growth hormones and their prolonged release compositions
NZ213630A (en) Acrylic acid derivatives and fungicidal compositions
EP0192533A3 (en) Alcalisilicate compositions and their use
EP0195323A3 (en) Soil release composition and use thereof
IL78934A0 (en) Alfuzosine compositions and use
GB8602259D0 (en) Metal powder-containing compositions
AR242340A1 (es) Material seleccionado entre extractos solubles en agua preparados a partir de tejidos de planta y fracciones separables de dichos extractos por cromatografia.
IL78592A0 (en) Antioxidant compositions and methods
NZ216159A (en) Thiene derivatives and yield-promoting compositions
NZ214522A (en) Pteridine derivatives and pharmaeutical compositions
GB2182323B (en) Settable compositions and methods of use thereof
AR242620A1 (es) Un procedimiento para producir una composicion de recubrimiento en polvo y el procedimiento para recubrir sustratos con dicha composicion.
EP0214102A3 (en) 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions
GB2178448B (en) Copper-chromium-titanium-silicon alloy and application thereof
GB8607913D0 (en) Powder metallurgy
GB8629181D0 (en) Preparation of group 11 metal alkyls
GR860075B (en) Compositions their preparation and use
GB2201418B (en) Preparation of metal alkyls
GR861727B (en) 5-substituted-6-aminopyridine derivatives composition and uses
NZ211872A (en) Chartreusin derivatives and antitumorous compositions
GB2160893B (en) Soldering compositions and methods of use
PH22087A (en) Antiandrogenic sulfonylsteroidopyrazoles and method of use and composition thereof
GB2179939B (en) 5-higher alkyl substituted-2h-benzotriazoles and stabilized compositions
EP0161234A3 (en) Polyglycidamides and coating compositions
EP0307665A3 (en) Encapsulation composition and use thereof